2006CARI繼發(fā)性膜性腎病的治療指南
《2006CARI繼發(fā)性膜性腎病的治療指南》內(nèi)容簡介：
Membranous nephropathy may occur secondary to conditions such as systemiclupus erythematosus （SLE）， drug therapy （gold, penicillamine, NSAIDs etc）， hepatitisB, malaria, schistosomiasis, syphilis and other infections, diabetes, thyroiditis andcertain malignancies （Brueggaemeyer et al 1987）。 In one series of 82 consecutiveCaucasian **s with MGN, secondary causes were identified in 17 patients （21%）including drugs, malignancy in four, thyroiditis, syphilis and hepatitis B virus infection（Cahen et al 1989）。
《2006CARI繼發(fā)性膜性腎病的治療指南》內(nèi)容預覽：
Databases searched: MeSH terms and text words for secondary membranousnephropathy. This search was carried out in Medline （1966 to September Week 12004）。 The Cochrane Renal Group Trials Register was also searched for trials ofmembranous nephropathy not indexed in Medline.
Date of searches: 9 September 2004.
What is the evidence?
There have been no randomised controlled trials.
Summary of the evidence
No recommendations can be made on the basis of current anecdotal evidence.
What do the other guidelines say?
Kidney Disease Outcomes Quality Initiative:No recommendation.
UK Renal Association: No recommendation.
Canadian Society of Nephrology: No recommendation.
European Best Practice Guidelines: No recommendation.
International Guidelines: No recommendation.
Implementation and audit
No recommendation.
Suggestions for future research
No recommendation.
點擊下載***：《2006CARI繼發(fā)性膜性腎病的治療指南》
本站所注明來源為"愛愛醫(yī)"的文章，版權(quán)歸作者與本站共同所有，非經(jīng)授權(quán)不得轉(zhuǎn)載。
本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的，且明確注明來源和作者，不希望被轉(zhuǎn)載的媒體或個人可與我們
聯(lián)系zlzs@120.net，我們將立即進行刪除處理
熱點圖文
-
急性腎功能衰竭時體內(nèi)代謝改變的特點是什么?
腎臟亦是參與機體代謝的器官之一,尤其是在水、電解質(zhì)與酸堿平衡的維持,代謝中...[詳細]
-
造影劑腎病的中國專家共識
造影劑腎病是碘造影劑應用過程中的重要并發(fā)癥，也是醫(yī)源性腎功能衰竭的重要組成...[詳細]
